Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abraha A, Schultz C, Konopelska-Bahu T, James T, Watts A, Stratton IM, Matthews DR, Dunger DB (1999) Glycaemic control and familial factors determine hyperlipidaemia in early childhood diabetes. Oxford Regional Prospective Study of Childhood Diabetes. Diabet Med 7: 598–604
Algvere P (1994) Prepubertal diabetes duration increases the risk of retinopathy. Acta Paediatr 83: 341
American Diabetes Association (2004) Standards of medical care for patients with diabetes mellitus. Diabetes Care 27: 15–35
Bachmann H, Horacek U, Leowsky M, Hirche H (1987) Blutdruck bei Kindern und Adoleszenten im Alter von 4 bis 18 Jahren. Monatsschr Kinderheilkd 135: 12
Benedetti A, Cattano G, Macor S, Noacco C (1975) Cheiroarthropathy of juvenile diabetes. Diabetologia 11: 332
Beyer J, Dieterle P, Gries FA, Hepp KD, Otto H, Schöffling K (1985) Therapie des Diabetes mellitus: Einstellungskriterien und Erfolgskontrollen. Diabetologie Inf 7: 14–18
Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J (1994) Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330: 15–18
Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J (1998). Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy. Diabet Med 15: 863–869
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813–820
Cook J, Daneman D, Spino M, Sochett E, Perlman K, Balfe JW (1990) Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus. J Pediatr 117: 39–45
Danne T, Kordonouri O (1998) Controversies on the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes. JPEM 11: 347–363
Danne T, Weber B, Hartmann R, Enders I, Burger W, Hovener G (1994) Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study. Diabetes Care 12: 1390–1396
Danne T, Kordonouri O, Hovener G, Weber B (1997) Diabetic angiopathy in children. Diabet Med 12: 1012–1025
Danne T, Kordonouri O, Enders I, Hovener G (1998) Monitoring for retinopathy in children and adolescents with type 1 diabetes. Acta Paediatr 425 (Suppl): 35–41
Danne T, Lange K, Schütz W von, Deiss D, Kordonouri O (2001a) Prävention der Langzeitfolgen. Monatsschr Kinderheilkd 149: 670–677
Danne T, Mortensen HB, Hougaard P et al. (2001b) Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care 24: 1342–1347
DCCT (Diabetes Control and Complications Trial) Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
DCCT (Diabetes Control and Complications Trial) Group (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 125: 177–188
DCCT (Diabetes Control and Complications Trial) Group (1995) The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44: 968–983
DCCT (Diabetes Control and Complications Trial) Group (1997) Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46: 1829–1839
DCCT (Diabetes Control and Complications Trial) Group (1998) Effect of intensive therapy on residual β-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 128: 517–523
DCCT/EDIC (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group) (White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group) (2001). Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT) J Pediatr 139: 804–812
DCCT/EDIC (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group) (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287: 2563–2569
DCCT/EDIC (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group; Nathan DM, Lachin J, Cleary P et al.) (2003) Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 348: 2294–2303
DDG (Deutsche Diabetes-Gesellschaft; Hammes HP, Bertram B, Bornfeld N et al.) (2000a) Diagnostik, Therapie und Verlaufskontrolle der diabetischen Retinopathie und Makulopathie. In: In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien DDG. 1. Aufl, Köln
DDG (Deutsche Diabetes-Gesellschaft; Haslbeck M, Luft D, Neundörfer B, Redaelli M, Stracke H, Ziegler D, Wienbeck M, Corvin S) (2000b). Diagnostik, Therapie und Verlaufskontrolle der autonomen diabetischen Neuropathie. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien DDG. 1. Aufl, Köln
DDG (Deutsche Diabetes-Gesellschaft; Haslbeck M, Redaelli M, Parandeh-Shab F, Luft D, Neundörfer B, Stracke H, Ziegler D) (2000c). Diagnostik, Therapie und Verlaufskontrolle der sensomotorischen diabetischen Neuropathien. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien DDG. 1. Aufl, Köln
DDG (Deutsche Diabetes-Gesellschaft; Haslbeck M, Redaelli M, Parandeh-Shab F, Luft D, Neundörfer B, Stracke H, Ziegler D) (2000d) Diagnostik, Therapie und Verlaufskontrolle der sensomotorischen diabetischen Neuropathie. Evidenzbasierte Diabetes-Leitlinien DDG, Köln
DDG (Deutsche Diabetes-Gesellschaft; Hasslacher C, Gandjour A, Redaelli M et al.) (2000e). Diagnose, Therapie und Verlaufskontrolle der Diabetischen Nephropathie. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien DDG. 1. Aufl, Köln
DDG (Deutsche Diabetes-Gesellschaft; Standl E, Fuchs C, Parandeh-Shab F et al.) (2000f) Management der Hypertonie beim Patienten mit Diabetes mellitus. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien DDG. 1. Aufl, Köln
DDG (Deutsche Diabetes-Gesellschaft; Haslbeck M, Luft D, Neundörper B et al.) (2002) Diagnose, Therapie und Verlaufskontrolle der autonomen diabetischen Neuropathie. Evidenzbasierte Diabetes-Leitlinien DDG, Köln
de Man SA, Andre JL, Bachmann H, Grobbee DE et al. (1991) Blood pressure in childhood: pooled findings of six European studies. J Hypertens 9: 109–114
Deckert T, Poulsen JE, Larsen M (1978) Prognosis of diabetics with diabetes onset before the age of thirtyone I: Survival, causes of death, and complications. Diabtologia 14: 363
Deckert T, Poulsen JE, Larsen M (1978) Prognosis of diabetics with diabetes onset before the age of thirtyone. II: Factors influencing the prognosis. Diabetologia 14: 371
Donaghue KC, Fung AT, Fairchild JM, Howard NJ, Silink M (1996) Prospective assessment of autonomic and peripheral nerve function in adolescents with diabetes. Diabet Med 13: 65–71
Donaghue KC, Fairchild JM, Craig ME et al. (2003) Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care 26: 1224–1229
Dyck PJ (1988) Detection, characterization and staging of polyneuropathy: Assessed in diabetics. Muscle Nerve 11: 21–32
Entmacher PS (1975) Longterm prognosis in diabetes mellitus. In: Sussmann KE, Meth RJS (eds) Diabetes mellitus. American Diabetes Association, New York, p 191
ETDRS (Early Treatment Diabetic Retinopathy Study Research Group) (1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98 (Suppl): 766–785
European Diabetes Policy Group, International Diabetes Federation (1998) A desktop guide to type 1 (insulin-dependent) diabetes mellitus
European IDDM Policy Group (1993) Consensus guidelines for the management of insulin-dependent (type I) diabetes. Medicom Europe BV, Bussum/NL
Feldt-Rasmussen B, Mathiesen ER, Jensen T et al. (1991) Effect of improved metabolic control on loss of kidney function in type I (insulin-dependent) diabetic patients: an update of the steno studies. Diabetologia 34: 164–170
Ferris FL (1993) How effective are treatments for diabetic retinopathy? J Am Med Wom Assoc 269: 1290–1291
Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339: 69–75
Forst T, Kunt T, Kazda C, Lobisch M, Pfützner A (2002) Die Rolle der Proteinkinase C in der Entwicklung mikrovaskulärer Komplikationen des Diabetes mellitus. Diabetes Stoffw 11: 62–70
Goldstein DE, Blinder KJ, Ide CH et al. (1993) Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study. Ophthalmology 100: 1125–1132
Grabert M, Schweiggert F, Holl RW (2002) A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Comput Methods Programs Biomed 69: 115–121
Greene DA, Arezzo JC, Brown MB (1999) Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology 53: 580–591
Hammes HP, Du X, Edelstein D et al. (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 3: 294–299
Hanssen KF, Bangstedt HJ, Brinchmann-Hansen O, Dahl-Jorgensen K (1992) Blood glucose control and microvascular complications: long-term effects of near-normoglycemia. Diabetic Med 9: 697–705
Hasslacher C, Danne T, Sawicki PT, Walter H (1998) Frühdiagnose der diabetischen Nephropathie. Dtsch Aerztebl 95: A51–53
Hauner H, Ferber F von, Köster I (1994) Ambulante Versorgung von Diabetikern. Eine Analyse von Krankenkassendaten der AOK Dortmund. DMW 199: 129–134
Hoffmann K, Gilde K, Hürter P, Jost J (1980) Diabetische Retinopathie bei Kindern und Jugendlichen. Ihre Abhängigkeit von der Stoffwechseleinstellung. Klin Monatsbl Augenheilkd 177: 482
Holl RW, Lang G, Grabert M, Teller W, Heinze E (1995) Spätkomplikationen bei Diabetes mellitus. Beginnt die Prävention schon in der Kindheit? Monatsschr Kinderheilkd 143:(Suppl. 1) 12–25
Holl RW, Lang GE, Grabert M, Heinze E, Lang GK, Debatin KM (1998) Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediatr 132: 790–794
Holl RW, Pavlovic M, Heinze E, Thon A (1999) Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care 22: 1151–1157
Hürter P, Schütz W von, Lange K (1995) Methoden der Insulin-substitution bei Kindern und Jugendlichen mit Typ-I-Diabetes. Monatsschr Kinderheilkd 143(Suppl 1): 39–53
International Society for Pediatric and Adolescent Diabetes, International Diabetes Federation, World Health Organisation (2000) Consensus guideline for the management of insulin-dependent (type I) diabetes mellitus (IDDM) in childhood and adolescence. Publ. Medforum, Zeist/NL, www.ispad.org, deutsche Fassung: www.disetronic.de/ download/0701_B_ISPAD.pdf
Javitt JC, Aiello LP, Chiang Y, Ferris L 3rd, Canner JK, Greenfield S (1994) Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care 17: 909–917
Joner G, Brinchmann-Hansen O, Torres CG, Hanssen KF (1992) A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian Type I (insulin-dependent) diabetic patients. Diabetologia 35: 1049–1054
Kasiske BL, Kalil RSN, Ma JZ, Liao M, Kane WF (1993) Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Am Intern Med 118: 129–138
Kimmelstiel P, Wilson C (1936) Intercapillary lesions in the glomeruli of the kidney. Am J Pathol 12: 83
Klein BE, Klein R, Meuer SM, Moss SE, Dalton DD (1988) Does the severity of diabetic retinopathy predict pregnancy outcome? J Diabetes Complications 2: 179–184
Kohner EM, Porta M (1992) Screening for diabetic retinopathy in Europe: A field guide-book. WHO-Copenhagen
Kokkonen J, Laatikainen L, Dickhoff K v, Miettinen R, Tuominen M, Lautala P, Salmela P (1994) Ocular complications in young adults with insulin-dependent diabetes mellitus since childhood. Acta Paediatr 83: 273–278
Kostraba JN, Dorman JS, Orchard TJ et al. (1989) Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 12: 686–692
Kroc Collaborative Study Group. Diabetic retinopathy after two years of intensified insulin treatment. J Am Med Assoc 1988: 260: 37–41
Kroll P, Bertram B (1997) Augenfachärztlicher Untersuchungsbogen zur Früherkennung diabetischer Augenerkrankungen. Z Prakt Augenheilk 18: 351–362
Lang-Muritano M, La Roche GR, Stevens JL, Gloor BR, Schoenle EJ (1995) Acute cataracts in newly diagnosed IDDM in five children and adolescents. Diabetes Care 10: 1395–1396
Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D (2002) Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347: 797–805
Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving HH (1999) Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 319: 24–25
Mogensen CE (1988) Management of diabetic renal involvement and disease. Lancet I: 867
Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH (1996) The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 124: 627–632
Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microlabuminuia in type 1 diabetes. N Engl J Med 348: 2285–2293
Reimers K, Auer P (1995) Diabetische Neuropathien. In: Berger M (Hrsg) Diabetes mellitus. Urban & Schwarzenberg, München, S 64–78, 512-528
Rosenbloom AL, Frias JL (1974) Diabetes, short stature and joint stiffness-a new syndrom. Clin Res 22: 92A
Rossing P, Hougaard P, Borch-Johnsen K, Parving HH (1996) Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 313: 779–784
Rudberg S, Ullman E, Dahlquist G (1993) Relationship between early metabolic control and the development of microalbuminuria — a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36: 1309–1314
Sawicki PT, Mühlhauser I, Didjurgeit U, Baumgartner A, Bender R, Berger M (1995) Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy. J Hypertens 13: 933–938
Schultz CJ, Konopelska-Bahu T, Dalton RN et al. (1999) Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Diabetes Care 22: 495–502
Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161–1165
Soergel M, Kirschstein M, Busch C et al. (1997) Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130: 178–184
Stephenson J, Fuller JH (1994) Microvascular and acute complications in IDDM patients: The Eurodiab IDDM complications study. Diabetologia 37: 278–285
Tuttle KR, Anderson PW (2003) A novel potential therapy for diabetic nephropathy and vascular complications: Protein kinase C βbeta inhibition. Am J Kidney Dis 42: 456–465
Viberti G (1988) Recent advances in understanding mechanisms and natural history of diabetic renal disease. Diabetes Care 11(Suppl 1): 3
Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36: 150–154
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
(2005). Folgeerkrankungen und Prognose des Typ—1—Diabetes. In: Diabetes bei Kindern und Jugendlichen. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-26602-X_6
Download citation
DOI: https://doi.org/10.1007/3-540-26602-X_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21186-0
Online ISBN: 978-3-540-26602-0
eBook Packages: Medicine (German Language)